10月9日，卫宁健康盘中上涨2.07%，截至13:38，报9.39元/股，成交3.23亿元，换手率1.83%，总市值 207.94亿元。 卫宁健康所属申万行业为：计算机-软件开发-垂直应用软件。所属概念板块包括：家庭医生概念、互联 医疗、DRG概念、智慧医疗、证金汇金等。 截至9月19日，卫宁健康股东户数11.78万，较上期减少0.53%；人均流通股16244股，较上期增加 0.53%。2025年1月-6月，卫宁健康实现营业收入8.39亿元，同比减少31.43%；归母净利润-1.18亿元，同 比减少491.04%。 分红方面，卫宁健康A股上市后累计派现4.55亿元。近三年，累计派现9722.63万元。 机构持仓方面，截止2025年6月30日，卫宁健康十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股5877.33万股，相比上期增加175.06万股。易方达创业板ETF（159915）位居第四大 流通股东，持股4526.36万股，相比上期减少65.23万股。招商优势企业混合A（217021）位居第十大流 通股东，持股2100.00万股，为新进股东。香港中央结算有限公司退出十大流通股东之列 ...

分红方面，太极股份A股上市后累计派现11.91亿元。近三年，累计派现2.84亿元。 9月25日，太极股份盘中上涨2.01%，截至10:29，报27.96元/股，成交1.70亿元，换手率0.99%，总市值 174.26亿元。 资金流向方面，主力资金净流入929.97万元，特大单买入875.89万元，占比5.15%，卖出1184.84万元， 占比6.97%；大单买入4192.63万元，占比24.67%，卖出2953.70万元，占比17.38%。 太极股份今年以来股价涨18.53%，近5个交易日涨4.45%，近20日跌5.57%，近60日涨23.18%。 资料显示，太极计算机股份有限公司位于北京市朝阳区容达路7号院中国电科太极信息产业园，成立日 期1987年10月10日，上市日期2010年3月12日，公司主营业务涉及提供行业解决方案与服务、IT咨询服 务、IT产品增值服务等。主营业务收入构成为：行业解决方案56.99%，数字基础设施14.66%，自主软 件产品14.14%，云与数据服务13.01%，其他1.20%。 太极股份所属申万行业为：计算机-IT服务Ⅱ-IT服务Ⅲ。所属概念板块包括：数字货币、数据要素、国 资 ...

Core Viewpoint - The stock of Weining Health has shown fluctuations in recent trading sessions, with a notable increase of 2.05% on September 24, 2023, while the company faces a significant decline in revenue and profit for the first half of 2025 [1][2]. Group 1: Stock Performance - As of September 24, 2023, Weining Health's stock price reached 8.96 CNY per share, with a market capitalization of 19.836 billion CNY [1]. - The stock has increased by 25.40% year-to-date, but has seen declines of 4.38% over the last five trading days, 15.39% over the last twenty days, and 10.22% over the last sixty days [1]. Group 2: Financial Performance - For the first half of 2025, Weining Health reported a revenue of 839 million CNY, a decrease of 31.43% year-on-year, and a net profit of -118 million CNY, representing a decline of 491.04% [2]. - The company has distributed a total of 455 million CNY in dividends since its A-share listing, with 97.226 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 19, 2023, the number of Weining Health's shareholders was 117,800, a decrease of 0.53% from the previous period, while the average number of circulating shares per person increased by 0.53% to 16,244 shares [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, which increased its holdings by 1.7506 million shares, and Yifangda Growth Enterprise ETF, which decreased its holdings by 652,300 shares [3].

Core Viewpoint - JiuYuan YinHai's stock price has shown fluctuations, with a recent decline of 2.12% and a year-to-date increase of 10.72%, indicating volatility in market performance [1][2]. Financial Performance - For the first half of 2025, JiuYuan YinHai reported a revenue of 439 million yuan, representing a year-on-year growth of 11.33%, and a net profit attributable to shareholders of 29.95 million yuan, which is a significant increase of 166.63% compared to the previous year [2]. - Cumulative cash dividends since the A-share listing amount to 472 million yuan, with 151 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2025, the number of shareholders increased to 58,300, up by 7.18%, while the average circulating shares per person decreased by 6.70% to 6,935 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 4.6232 million shares, an increase of 910,200 shares from the previous period, and Southern CSI 1000 ETF, holding 2.6339 million shares, up by 489,700 shares [3]. Business Overview - JiuYuan YinHai, established on November 24, 2008, and listed on December 31, 2015, focuses on software products, operation services, and system integration in the field of social security and human resources [1]. - The company's revenue composition includes 49.40% from operation services, 34.76% from software, and 15.60% from system integration [1].

Company Overview - Seer Medical Technology Group Co., Ltd. is located in Wuhan, Hubei Province, and was established on February 23, 2004. It was listed on October 31, 2016. The company's main business includes centralized marketing and service for medical testing, as well as the agency, research, production, and sales of in vitro diagnostic products [2]. Business Segmentation - The revenue composition of Seer Medical is as follows: IVD business accounts for 39.91%, SPD business for 38.01%, and pure sales for 22.08% [2]. Financial Performance - For the first half of 2025, Seer Medical reported a revenue of 584 million yuan, a year-on-year decrease of 40.20%. The net profit attributable to shareholders was -56.12 million yuan, representing a year-on-year decrease of 1075.89% [2]. Stock Performance - On September 4, Seer Medical's stock price fell by 2.02%, trading at 29.07 yuan per share, with a total market capitalization of 6.109 billion yuan. The stock has increased by 302.63% year-to-date, but has seen a decline of 12.18% over the last five trading days [1]. Trading Activity - Seer Medical has appeared on the trading leaderboard 37 times this year, with the most recent appearance on August 26, where it recorded a net buy of 146 million yuan. The total buy amounted to 489 million yuan, accounting for 18.85% of total trading volume, while total sales reached 343 million yuan, making up 13.22% of total trading volume [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Seer Medical was 45,700, a decrease of 1.94% from the previous period. The average circulating shares per person increased by 1.97% to 4,180 shares [2]. Dividend History - Since its A-share listing, Seer Medical has distributed a total of 27.0741 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of June 30, 2025, the top ten circulating shareholders included the Caifeng Advantage Industry Rotation Mixed Fund (011201), which held 643,400 shares, marking it as a new shareholder [3].

Group 1 - The core viewpoint of the news is that Neusoft Corporation's stock has experienced fluctuations, with a recent decline of 2.01% and a total market capitalization of 12.747 billion yuan [1] - As of August 29, Neusoft's stock price is 10.71 yuan per share, with a trading volume of 274 million yuan and a turnover rate of 2.13% [1] - Year-to-date, Neusoft's stock price has increased by 0.85%, with a 7.42% rise over the past 20 trading days [1] Group 2 - Neusoft's main business includes software technology, industry solutions, software products, platforms, services, and medical equipment, with 85.92% of revenue coming from proprietary software, products, and services [1] - As of June 30, Neusoft reported a revenue of 4.689 billion yuan for the first half of 2025, representing a year-on-year growth of 9.08%, while net profit attributable to shareholders decreased by 42.75% to 56.2704 million yuan [2] - The company has distributed a total of 1.894 billion yuan in dividends since its A-share listing, with 332 million yuan distributed in the last three years [3]

Core Viewpoint - Weining Health has shown significant stock performance with a year-to-date increase of 55.35%, indicating strong market interest and potential growth in the healthcare software sector [1]. Group 1: Stock Performance - As of August 26, Weining Health's stock price reached 11.10 CNY per share, with a trading volume of 1.15 billion CNY and a turnover rate of 5.53%, resulting in a total market capitalization of 24.56 billion CNY [1]. - The stock has experienced a 4.91% increase over the last five trading days, a 5.71% increase over the last twenty days, and a 17.15% increase over the last sixty days [1]. - The company has appeared on the "龙虎榜" (top trading list) twice this year, with the most recent occurrence on February 7 [1]. Group 2: Financial Performance - For the first half of 2025, Weining Health reported a revenue of 839 million CNY, reflecting a year-on-year decrease of 31.43%, and a net profit attributable to shareholders of -118 million CNY, a significant decline of 491.04% [2]. - Cumulative cash dividends since the company's A-share listing amount to 455 million CNY, with 97.23 million CNY distributed over the past three years [3]. Group 3: Shareholder Structure - As of August 8, the number of Weining Health's shareholders reached 123,200, an increase of 1.39%, while the average number of circulating shares per shareholder decreased by 1.37% to 15,525 shares [2]. - The top three circulating shareholders include Huabao Zhongzheng Medical ETF, holding 58.77 million shares (an increase of 1.75 million shares), and Yifangda Growth Enterprise Board ETF, holding 45.26 million shares (a decrease of 0.65 million shares) [3].

Core Viewpoint - 嘉和美康's stock price has shown significant growth this year, with a year-to-date increase of 47.94% and a recent trading performance indicating continued interest from investors [1][2] Group 1: Stock Performance - As of August 22, 嘉和美康's stock price reached 36.69 yuan per share, with a market capitalization of 5.048 billion yuan [1] - The stock has experienced a 3.06% increase over the last five trading days and a 26.39% increase over the last 60 days [1] - The company has appeared on the龙虎榜 twice this year, with the most recent appearance on February 17 [1] Group 2: Financial Metrics - For the period from January to March 2025, 嘉和美康 reported a revenue of 101 million yuan, reflecting a year-on-year decrease of 17.43% [2] - The number of shareholders increased by 3.10% to 5,893, with an average of 23,347 circulating shares per shareholder, up 32.19% [2] Group 3: Company Overview - 嘉和美康 (Beijing Jiameikang Technology Co., Ltd.) was established on March 3, 2006, and went public on December 14, 2021 [1] - The company operates in the medical information software sector and is categorized under the computer-software development industry, focusing on vertical application software [1]

Group 1 - The stock price of Neusoft Corporation increased by 2.30% on August 22, reaching 10.67 CNY per share, with a total market capitalization of 12.689 billion CNY [1] - Year-to-date, Neusoft's stock price has risen by 0.47%, with a 5-day increase of 5.64%, a 20-day increase of 6.70%, and a 60-day increase of 10.11% [1] - As of March 31, 2025, Neusoft had 100,100 shareholders, an increase of 21.28% from the previous period, with an average of 12,025 circulating shares per shareholder, a decrease of 17.55% [2] Group 2 - For the first quarter of 2025, Neusoft reported revenue of 1.850 billion CNY, a year-on-year increase of 1.06% [2] - Neusoft has distributed a total of 1.894 billion CNY in dividends since its A-share listing, with 332 million CNY distributed over the past three years [2] - The top ten circulating shareholders of Neusoft include Hong Kong Central Clearing Limited, which holds 45.7619 million shares, a decrease of 15.8491 million shares from the previous period [2]

Core Viewpoint - The A-share market opened with mixed results, as the Shanghai Composite Index rose by 0.07%, while the Shenzhen Component Index and the ChiNext Index fell by 0.02% and 0.16%, respectively [1] Industry Summary - The high-pressure oxygen chamber, DRG concept, and liquid cooling service sectors showed significant gains, leading the market in terms of growth [1]